Clinical Trial: A Study of SKB107 in Advanced Solid Tumors With Bone Metastases

U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07087197) titled 'A Study of SKB107 in Advanced Solid Tumors With Bone Metastases' on June 30.

Brief Summary: A multicenter, open-label Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics, dosimetry and efficacy of SKB107 in subjects with advanced solid tumors with bone metastases.

Study Start Date: Aug. 01

Study Type: INTERVENTIONAL

Condition: Metastatic Solid Tumors

Intervention: DRUG: SKB107 for injection

177Lu-DOTA-IBA is a Radionuclide conjugated drugs (RDC) targeting bone.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.

Published by HT Digital Content ...